Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2026-01-28 @ 6:16 PM
Study NCT ID:
NCT06239194
Status:
RECRUITING
Last Update Posted:
2025-06-22
First Post:
2024-01-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Sponsor:
ModeX Therapeutics, An OPKO Health Company
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Biliary Tract Cancer | View |
| None | Breast Cancer | View |
| None | Cervical Cancer | View |
| None | Colon Cancer | View |
| None | Endometrial Cancer | View |
| None | Esophageal Cancer | View |
| None | Gastric Cancer | View |
| None | GastroEsophageal Cancer | View |
| None | Head and Neck Cancer | View |
| None | Hepatocellular Cancer | View |
| None | Non-small Cell Lung Cancer | View |
| None | Pancreatic Cancer | View |
| None | Prostate Cancer | View |
| None | Rectal Cancer | View |
| None | Renal Cancer | View |
| None | Thyroid Cancer | View |
Keywords: